Medicare Compliance & Reimbursement - 2003 Issue 33
Pharmaceuticals: Medicare Hatches Plans To Slash DME Drug Payments
Subscribe or sign in to view the full article.
Article Overview
This article explains a proposed Centers for Medicare & Medicaid Services rule affecting Medicare drug payment policy and the potential implications for durable medical equipment suppliers, in-house pharmacies, and other pharmacies that dispense inhalation and infusion-related drugs. It is relevant to homecare and medical product suppliers, pharmacy stakeholders, and coding/billing professionals tracking federal reimbursement policy changes and comment opportunities. The discussion focuses on proposed payment changes, administrative service costs, and the broader access concerns raised by industry groups.
Why This Topic Matters
It helps readers understand a pending Medicare payment policy change that may affect reimbursement, service costs, and access to drug-related homecare therapies for patients.
What You Will Learn
- What the proposed Medicare drug pricing rule addresses
- How the rule may affect durable medical equipment suppliers and pharmacies
- Why industry groups are concerned about administrative service costs
- What CMS says about existing payment structure and proposed add-on concepts
- When comments are due and when a final rule is expected
Who Should Read This
- Durable medical equipment suppliers
- Pharmacies
- Homecare providers
- Medical billing and coding professionals
- Reimbursement and compliance staff
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com